3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Non-Small-Cell Lung
3
Head and Neck Neoplasms
2
Tongue Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrent Head and Neck Carcinoma
1
Precancerous Conditions
1
Pleural Effusion, Malignant
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Leukoplakia, Oral
1
Laryngeal Neoplasms
1
Barrett Esophagus
1
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
Dihematoporphyrin Ether
×
Clear all
No trials found.